(IN BRIEF) Dr Amanda Pearce of Loughborough University has received a substantial grant from the Academy of Medical Sciences as part of the Springboard programme, which supports 62 early-career researchers across the UK with awards ranging from £100,000 to £125,000. … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, Alzheimer’s disease, blood-brain barrier, career development, CRISPR/Cas9 therapy, dementia, DNA modification, Dr Amanda Pearce, early-career researchers, fluorescent polymer nanoparticles, Healthcare Innovation, leadership, Loughborough University, mentoring, neurodegenerative diseases, NHS burden, research funding, Springboard programme, UK science
(IN BRIEF) Researchers at TU Delft, led by Angelo Accardo, have developed a groundbreaking 3D-printed model that replicates the brain’s environment to study how neurons grow and form networks. Using nanopillar arrays, the team mimicked the mechanical and geometric properties … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged 3D-printed model, Advanced Functional Materials, Alzheimer's, Angelo Accardo, applied physics, autism, brain tissue, brain-like environment, ErasmusMC, extracellular matrix, growth cones, mechanical engineering, nanopillar arrays, network formation, neurodegenerative diseases, neurological disorders, neuron growth, neuron maturation, neurons, neuroscience, Parkinson's, RESEARCH, scientific innovation, TU Delft, two-photon polymerization
Cordoba, Spain, 12-6-2013 — /europawire.eu/ — VivaCell Biotechnology España S.L., Cordoba, Spain today announced that it has entered into joint Research Collaboration and Commercialization Agreements with Aphios Corporation, USA, to develop therapeutics for multiple sclerosis and other neurodegenerative diseases of the central … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Spain
Tagged Aphios Corporation, biotech company, biotech development, biotech pharma companies, biotechnology, cannabinoid receptor, cannabinoids, central nervous system, CNS and neurological disorders, Cordoba, endocannabinoid system, multiple sclerosis, neurodegenerative diseases, novel class of compounds, therapeutics for multiple sclerosis, VivaCell Biotechnology, VivaCell Biotechnology España S.L.
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?